Skip to content
Search

Latest Stories

Embracing data in pharmacy

With technology and AI shaping the futures of so many industries, Dr Yasmin Karsan looks at how data can be a springboard for community pharmacies to enhance their service.

Why is Data important in Pharmacy?
Data enables businesses and organisations to gain insights, predict trends to make evidence-based decisions.
Getty Images

Why is Data important in Pharmacy?

Data plays a significant role in our technology enabled lives. It has become one of the most valuable assets - every click and every swipe leads on to a data point which can be used to develop our digital persona.

We have all had that moment where we think ‘our phones are listening to us’ – in this instance we receive targeted advertising on products, we have discussed out loud. Similarly, gathering targeted data points of patients can support targeted healthcare delivery. Each prescription, dispensed item and line on the Summary Care Record can act as a data point for a patient, formulating a picture of that patient’s health.


In some areas this is known as a ‘Digital Twin’. Digital Twins are an incredible asset in patient care, but prior to discussing them it is critical to understand the data which underpins their development.

Exploring the role of data in pharmacy - the significance, types, sources, and applications of data can help transform the industry.

What is data?

Data is factual information which can be used as insights for informed decision making. Nominally data points are key areas whereby there is an interaction between a human and a computer, e.g. a click, a swipe, a blood test.

Data enables businesses and organisations to gain insights, predict trends to make evidence-based decisions. In the healthcare sector, data plays a focal role, as the outcomes can directly impact patient care, treatment plans, and healthcare delivery.

The importance of data in pharmacy

Historically, pharmacies have always generated numerous data points, however technology had not caught up with its utility until now.

Data is central to enhancing decision-making processes in pharmacy. Accurate data enables pharmacy teams to make informed decisions regarding medication management, patient safety, and treatment efficacy.

In terms of real-world application – our consultations are data gathering exercises. We utilise this data to make an informed decision on the patients issues and subsequently provide the most appropriate care e.g. a treatment, advice etc.

Technology can be used to transform and understand data. Using mathematical models, insights can be gained to support operations, patient safety and healthcare service delivery in a more efficient manner which may take a human longer to do. In some instances, this is also known as Artificial Intelligence which comes with its own regulatory requirements.

Data empowers pharmacy teams to engage in proactive healthcare. Future areas for usage in data consists of predictive analytics. These can identify patients of interest for example those at risk of non-adherence or potential side effects.

On a wider scale data also plays a role in public health initiatives, such as tracking vaccination rates and managing responses to health crises like pandemics.

Types of data in pharmacy

  1. Clinical Data: This includes patient health records, laboratory results, diagnostic images, and information about prescribed medications.
  2. Pharmaceutical Data: Data related to drug formulations, pharmacokinetics, pharmacodynamics.
  3. Operational Data: Data from pharmacy operations, including stock levels, sales records and staffing.
  4. Regulatory and Compliance Data: Involves data required to meet legal and regulatory standards, such as documentation for controlled substances and adverse event reporting.
  5. Patient-Generated Data: Information collected directly from patients, including medication adherence data, lifestyle information, and self-reported symptoms.

Sources of Pharmacy Data

  • Electronic Health Records (EHRs): Comprehensive digital records of patients’ medical histories that facilitate coordinated care among healthcare providers.
  • Pharmacy Management Records: Software solutions that handle prescription processing, inventory, and billing, streamlining pharmacy operations.
  • Clinical Trials: Research studies that provide valuable data on drug efficacy and safety.
  • Pharmacovigilance Databases (e.g. MHRA Yellow Card): Repositories that track adverse drug reactions and safety issues, supporting drug safety monitoring.

Challenges in Managing Pharmacy Data

  • Data Privacy and Security: Protecting sensitive patient information from unauthorised access is paramount. Pharmacies must implement robust cybersecurity measures and comply with data protection regulations. E.g. DSPT toolkit.
  • Data Integration: Combining data from various sources to create a cohesive and comprehensive dataset remains a challenge. Interoperability between different healthcare systems is essential for seamless data sharing.
  • Data Quality: Ensuring the accuracy, consistency, and completeness of data is critical for reliable decision-making. Poor data quality can lead to medication errors and compromised patient safety.

Future Trends in pharmacy data

As technology advances, the role of data in pharmacy will continue to expand. Artificial intelligence (AI) and machine learning are set to revolutionise pharmacy practices by enabling predictive analytics, automating routine tasks, and uncovering new insights from complex datasets.

The future

Data will become an indispensable asset in pharmacy, driving improvements in patient care, operational efficiency, and drug development.

As technology continues to advance, the role of data in pharmacy will only grow, offering new opportunities for innovation and enhanced healthcare outcomes. Understanding the fundamentals of data in pharmacy is essential for professionals aiming to stay at the forefront of this evolving field.

Data enables businesses to make evidence-based decisionsDr Yasmin Karsan

Written by Dr Yasmin Karsan, MRPharmS

Community Pharmacist, Clinical Safety Officer and AI Consultant.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
Community pharmacy must now focus on matters in their direct control

The new Community Pharmacy Contractual Framework is a step in the right direction - Victoria Steele

Victoria Steele

Community pharmacy shouldn’t rely solely on CPCF income

Over the coming days much will be/is being written about the Community Pharmacy Contractual Framework and the Independent Economic Review. Emotions are understandably high this week and as everyone has already said, the devil is in the detail.

I must admit to being puzzled by the behaviours that I’m witnessing, and energy being expended at Community Pharmacy England’s door rather than that of government. Only those in the room whilst negotiating will know what information they were dealing with and as is always the case in these situations, they (CPE) are undoubtedly in an unenviable position where nothing they could do would have been right (or certainly not enough).

Keep ReadingShow less
A Royal College of Pharmacy

A Royal College of Pharmacy will aim to have a united voice

Pic credit: iStock

A Royal College of Pharmacy:  The what, the why and the how

By Mike Holden,

The what

Keep ReadingShow less